Peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (roferon-A) plus RBV and AMA in IFN/RBV nonresponder patients with chronic hepatitis C (CHC)
- 30 April 2003
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 38, 139-140
- https://doi.org/10.1016/s0168-8278(03)80745-6
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: